Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01279577
What this trial is testing

Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease

Who this might be right for
Crohn´s Disease
Dr. Falk Pharma GmbH 254
Not applicableStudy completedNCT02426567
What this trial is testing

The Impact of "Crohn's Disease-TReatment-with-EATing" Diet and Exclusive Enteral Nutrition on Healthy Gut Bacteria

Who this might be right for
Crohn's DiseaseDietary Modification
University of Glasgow 28
Post-approval studies (Phase 4)UnknownNCT02597829
What this trial is testing

Does Clinical Response Correlate With Serum Certolizumab Levels?

Who this might be right for
Crohn's Disease
Shafran Gastroenterology Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07113522
What this trial is testing

Evaluate Therapies for Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Disease (IBD)Ulcerative Colitis (UC)Crohn's Disease
Mirador Therapeutics, Inc. 140
Large-scale testing (Phase 3)Looking for participantsNCT07184931
What this trial is testing

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 980
Large-scale testing (Phase 3)Study completedNCT00552058
What this trial is testing

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB Pharma 439
Post-approval studies (Phase 4)Looking for participantsNCT07663526
What this trial is testing

Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®

Who this might be right for
Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT01345799
What this trial is testing

TRK-170 for the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Toray Industries, Inc 123
Testing effectiveness (Phase 2)Looking for participantsNCT06456593
What this trial is testing

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn Disease
Abivax S.A. 212
Testing effectiveness (Phase 2)Looking for participantsNCT07483073
What this trial is testing

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn Disease
Eli Lilly and Company 60
Not applicableStudy completedNCT04827368
What this trial is testing

Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease

Who this might be right for
IBDCrohn DiseaseUlcerative Colitis
The Cleveland Clinic 292
Not applicableUnknownNCT06116331
What this trial is testing

The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+1 more
King's College London 170
Large-scale testing (Phase 3)Study completedNCT03782376
What this trial is testing

Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen-Cilag Ltd. 215
Large-scale testing (Phase 3)Ended earlyNCT02240108
What this trial is testing

One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease

Who this might be right for
Crohn's Disease
Bausch Health Americas, Inc. 81
Post-approval studies (Phase 4)Looking for participantsNCT06581328
What this trial is testing

Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 200
Not applicableLooking for participantsNCT06890637
What this trial is testing

Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies

Who this might be right for
Crohns Disease
All India Institute of Medical Sciences 168
Not applicableStudy completedNCT02559037
What this trial is testing

Acupuncture Treatment for Active Crohn's Disease

Who this might be right for
Crohn's Disease
Shanghai Institute of Acupuncture, Moxibustion and Meridian 66
Not applicableNot Yet RecruitingNCT07788131
What this trial is testing

Inflammatory Biomarkers and Disease Activity in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis (UC)
Assiut University 120
Testing effectiveness (Phase 2)Study completedNCT00040521
What this trial is testing

Study Evaluating rhIL-11 in Active Crohn's Disease

Who this might be right for
Crohn DiseaseInflammatory Bowel Disease
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableUnknownNCT05407350
What this trial is testing

Validation of an IUS Activity Index

Who this might be right for
Crohn Disease
International Bowel Ultrasound Group e.V. 110
Next Page